Company: RVRC
Filing Date: 2025-10-03
Form Type: S-1/A
Source: 0001213900-25-096094
Chunk: 68

Company: Revium Rx.
Filing Date: 2025-10-03
Form: S-1/A
Chunk 68
---
 Loss

As a result of the foregoing, Successor’s
loss totaled $1,606 thousand for the six months period ended June 30, 2025, representing an increase of $205 thousand, or 14.6%, compared
to Predecessor’s $1,401 thousand for the same period.

Successor for the three months period ended June 30, 2025, the Predecessor for the three months period ended June 30, 2024

The following tables present selected financial
data for the Successor for the three months period ended June 30, 2025 and the Predecessor for the three months period ended June 30,
2024.

|                                     |     |    Successor |     |     |  Predecessor |     |
|                                     |     |      For the 
 three months 
        ended 
     June 30, |     |     |      For the 
 three months 
        ended 
     June 30, |     |
|                                     |     |         2025 |     |     |         2024 |     |
| Operating expenses                  |     |              |     |     |              |     |
| Research and development expenses   |     |              | 391 |     |              | 576 |
| General and administrative expenses |     |              | 547 |     |              | 173 |
| Operating loss                      |     |              | 938 |     |              | 749 |
| Financial income, net               |     |              |  34 |     |              |   2 |
| Net loss and comprehensive loss     |     |              | 972 |     |              | 751 |

<div align='center'>39</div>

Research and Development Expenses

Successor’s research and development
expenses totaled $391 thousand for the three months period ended June 30, 2025, representing a decrease of $185 thousand, or 32.1%, compared
to Predecessor’s $576 thousand for the same period. The research and development expenses comprise mainly from salaries and related
expenses, from share based payment expenses and other expenses. The decrease was mainly due to lower share based payment expense recorded
in the three months period ended June 30, 2025 compared with the same period in 2024.

General and Administrative Expenses

Successor’s general and administrative
expenses totaled $547 thousand for the three months period ended June 30, 2025, representing an increase of $